Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Makarova, L. Slogotskaya, E. Kupavtseva, S. Borisov (Moscow, Russian Federation). The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases. Eur Respir J 2011; 38: Suppl. 55, 294

Member's Comments

No comment yet.

Related content which might interest you: The significance of the antigen-specific IFN-γ release assay in vitro for differential diagnosis between sarcoidosis and tuberculosis (TB) patients Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 New skin testing with DIASKINTEST® (recombinant protein CFP10-ESAT6) in TB diagnosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004 The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Silica exposure, silicosis, autoimmune diseases, tuberculosis and nontuberculous pulmonary mycobacterial disease Source: International Congress 2016 – Occupational epidemiology Year: 2016 Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis? Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Radiological findings and isolation days of pulmonary tuberculosis patients – comparison between active smokers and non-smokers/former-smokers Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009 Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Nontuberculous mycobacterial adenitis: the diagnostic value of interferon-γ release assays Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Comparative results of the QuantiFERON laboratory test with a skin test containing the recombinant protein CFP-10-ESAT-6 and a Mantoux test with 2 TE in children with chronic non-specific lung diseases and tuberculosis. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Prospective study of concordance between tuberculin skin test (TST) and interferon-γ (IFNγ) assay in asymptomatic paediatric tuberculosis (TB) contacts Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection Year: 2009 Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients? Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Pulmonary tuberculosis – Still a challenging diagnosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011